✨ New Arrivals Just Dropped!Explore
B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs
HomeStore

B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs

B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs

$106.75

Original: $305.00

-65%
B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs

$305.00

$106.75

The Story

B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs

Model: S5104-5384
Strength / Concentration: 5% dextrose
Container / Fill: 50 mL fill in 100 mL PAB® (Partial Additive Bag) container
84 Containers/ Case

EXCEL & PAB, the only PVC-free, DEHP-free containers with a full range of basic IV solutions. EXCEL & PAB eliminate the risk of plasticizer toxicity, reduces the risk of sub-therapeutic dosing and facilitate inspection of admixtures.

The B. Braun 5% Dextrose Injection (50 mL fill in 100 mL PAB container) is designed for intravenous administration in settings where patients require both hydration and a modest source of calories. Its isotonic 5% dextrose solution helps maintain fluid balance while supplying a simple carbohydrate substrate which can be metabolized to support glycogen deposition and reduce nitrogen losses—making it a practical choice for patients unable to eat or drink.

What distinguishes this product is its packaging and material composition: the PAB® (Partial Additive Bag) container is free of PVC and DEHP, and contains no natural rubber latex. This reduces risks of plasticizer contamination or latex allergy reactions—an important consideration in sensitive patient populations or neonatal/infant care. The container also allows for medication additives if needed, and the solution is supplied without antimicrobial preservatives, making it suitable for single‑use additive protocols under aseptic technique.

From a supply‑chain and clinical workflow perspective, the 84‑unit case size supports efficient stocking in hospital pharmacies or infusion units. Facilities benefit from its relatively compact size and moderate shipping weight, making it manageable for storage in critical care or step‑down units. Its broad indication for both adult and pediatric use, combined with the straightforward electrolyte profile (pure dextrose in water), gives clinicians a versatile fluid option when more complex electrolyte mixtures are not required. Overall, this solution offers a balanced approach to hydration, caloric support, and material safety in IV therapy settings.

Description

B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs

Model: S5104-5384
Strength / Concentration: 5% dextrose
Container / Fill: 50 mL fill in 100 mL PAB® (Partial Additive Bag) container
84 Containers/ Case

EXCEL & PAB, the only PVC-free, DEHP-free containers with a full range of basic IV solutions. EXCEL & PAB eliminate the risk of plasticizer toxicity, reduces the risk of sub-therapeutic dosing and facilitate inspection of admixtures.

The B. Braun 5% Dextrose Injection (50 mL fill in 100 mL PAB container) is designed for intravenous administration in settings where patients require both hydration and a modest source of calories. Its isotonic 5% dextrose solution helps maintain fluid balance while supplying a simple carbohydrate substrate which can be metabolized to support glycogen deposition and reduce nitrogen losses—making it a practical choice for patients unable to eat or drink.

What distinguishes this product is its packaging and material composition: the PAB® (Partial Additive Bag) container is free of PVC and DEHP, and contains no natural rubber latex. This reduces risks of plasticizer contamination or latex allergy reactions—an important consideration in sensitive patient populations or neonatal/infant care. The container also allows for medication additives if needed, and the solution is supplied without antimicrobial preservatives, making it suitable for single‑use additive protocols under aseptic technique.

From a supply‑chain and clinical workflow perspective, the 84‑unit case size supports efficient stocking in hospital pharmacies or infusion units. Facilities benefit from its relatively compact size and moderate shipping weight, making it manageable for storage in critical care or step‑down units. Its broad indication for both adult and pediatric use, combined with the straightforward electrolyte profile (pure dextrose in water), gives clinicians a versatile fluid option when more complex electrolyte mixtures are not required. Overall, this solution offers a balanced approach to hydration, caloric support, and material safety in IV therapy settings.

B BRAUN S5104-5384 DEXTROSE INJECTIONS USP Dextrose Injections, 5%, 50/100mL, PAB® Containers, 84/cs | Primis Medical